FGF21 alleviates microvascular damage following limb ischemia/reperfusion injury by TFEB-mediated autophagy enhancement and anti-oxidative response

Signal Transduct Target Ther. 2022 Oct 12;7(1):349. doi: 10.1038/s41392-022-01172-y.

Fanfeng Chen^#^{1

2}, Jiayu Zhan^#², Xiaoqing Yan^#², Abdullah Al Mamun², Yu Zhang², Yitie Xu², Hongyu Zhang², Xiaokun Li³, Kailiang Zhou⁴, Jian Xiao^{5

6}

¹ Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
² Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
³ Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China. xiaokunli@wmu.edu.cn.
⁴ Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. zhoukailiang@wmu.edu.cn.
⁵ Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Department of Vascular Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. xfxj2000@126.com.
⁶ Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China. xfxj2000@126.com.

^# Contributed equally.

No abstract available

Publication types